Healthcare

Gastroesophageal Reflux Disease (GERD) Device Market to Reach USD 1.9 Billion by 2036 as Advanced Reflux Diagnostics and Minimally Invasive Procedures Improve Treatment Outcomes

NEWARK, Del., July 1, 2026, 11:19 GMT-04

FMI-GERD-device-mkt

Read full article →

Global Oncology-Based In-Vivo CRO Market to Accelerate Substantially at a CAGR of ~8% by 2034 | DelveInsight

LAS VEGAS, July 1, 2026, 10:46 GMT-04

DELVEINSIGHT

Read full article →

High-Grade Glioma Market Witnesses Strong Momentum During the Forecast Period (2026-2036) with Increasing Clinical Activity and Drug Development | DelveInsight

LAS VEGAS, July 1, 2026, 10:31 GMT-04

DELVEINSIGHT-health

Read full article →

Hansa Biopharma announces closing of €115 million licensing transaction with SERB Pharmaceuticals for Idefirix in Europe and MENA

LUND, Sweden, July 1, 2026, 09:24 GMT-04

HANSA-BIOPHARMA-SERB

Read full article →

SkylineDx's Merlin CP-GEP Granted FDA Breakthrough Device Designation, Building on Exclusive NCCN Recognition in Melanoma Care

ROTTERDAM, Netherlands and SAN DIEGO, July 1, 2026, 03:00 GMT-04

SkylineDx

Read full article →

SciBase Submits FDA 510(k) to Expand Nevisense into the Largest Skin Cancer Market

STOCKHOLM, July 1, 2026, 02:53 GMT-04

SCIBASE-submit-FDA

Read full article →

Active Care Group announces landmark development of new private specialist rehabilitation hospital in Stoke Mandeville

STOKE MANDEVILLE, England, July 1, 2026, 19:01 GMT-04

ACTIVE-CARE-new-hosp

Read full article →

Magnetic Resonance Imaging (MRI) Market to Reach USD 10.2 Billion by 2036 as AI Reconstruction and Low-Helium Systems Improve Imaging Efficiency | FMI

NEWARK, Del., June 30, 2026, 11:30 GMT-04

FMI-Magnetic-Resonanc

Read full article →

Long-Acting Drugs Market to Reach US$ 13.3 Billion by 2033 Expands Amid Advances in Sustained Drug Delivery and Chronic Disease Management - Persistence Market Research

LONDON, June 30, 2026, 10:46 GMT-04

Persistence-Market-Re

Read full article →

Warm Autoimmune Hemolytic Anemia Market to Observe Stunning Growth at a 14.4% CAGR During the Forecast Period (2026-2036) Due to the Emergence of Novel Drug Classes Such as FcRn Inhibitors, BTK Inhibitors, BAFF-R, and Others | DelveInsight

LAS VEGAS, June 30, 2026, 10:31 GMT-04

DELVEINSIGHT

Read full article →

Body Fluid Analysis Market worth $3.65 billion by 2031 | MarketsandMarkets™

DELRAY BEACH, Fla., June 30, 2026, 10:30 GMT-04

MARKETSANDMARKETS

Read full article →

Selective PPARα Modulator "K-808" (Pemafibrate) Granted "Breakthrough Therapy" Designation by the U.S. Food and Drug Administration (FDA) As a Treatment for Primary Biliary Cholangitis

NAGOYA, Japan, June 30, 2026, 10:00 GMT-04

Kowa-FDA-PBC

Read full article →

Shantha Biologics Announces Cartridge Fill-Finish Collaboration

HYDERABAD, India, June 30, 2026, 09:13 GMT-04

SHANTHA-BIOLOGICS-con

Read full article →

New Human Study in Nature's Scientific Reports Finds Candela's Nordlys® Non-Ablative Fractional Laser Reverses the Skin's Epigenetic Signature of Aging

MARLBOROUGH, Mass., June 30, 2026, 09:07 GMT-04

Candela-Corporation

Read full article →

Cumulus Neuroscience Announces Publication in Frontiers in Digital Health Demonstrating the NeuLogiq® Platform Is Feasible and Usable for At-Home Cognitive and EEG Assessment in People Living with Mild Alzheimer's Disease Dementia

BELFAST, Northern Ireland and DUBLIN, June 30, 2026, 09:00 GMT-04

CUMULUS-NEUROSCIENCE

Read full article →

Skyhawk Therapeutics Releases Twelve-Month cUHDRS Subcomponent Results from its Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease

BOSTON, June 30, 2026, 07:05 GMT-04

Skyhawk-Therapeutics

Read full article →

CU Medicine Ranked World No. 2 in Gastroenterology & Hepatology

HONG KONG, June 30, 2026, 05:52 GMT-04

CUHK-RANKED

Read full article →

Salt Medical Achieves ISO 13485 Certification, Reinforcing Its Position as a Full-Lifecycle Partner for Medical Device Companies

GALWAY, Ireland, June 30, 2026, 04:00 GMT-04

Salt-Medical

Read full article →

New clinical and real-world evidence on Lecanemab to be presented at AAIC conference 2026

STOCKHOLM, June 30, 2026, 02:53 GMT-04

BioArctic-Lecanemab

Read full article →

IGEL Appoints James Millington as Field CTO for Healthcare in EMEA

LONDON, June 29, 2026, 13:53 GMT-04

IGEL-Healthcare

Read full article →